Ticker

No recent analyst price targets found for GTHP.

Latest News for GTHP

Guided Therapeutics Receives $80,000 Payment as Fourth Installment of $700,000 Purchase Order with Chinese Distributor

PEACHTREE CORNERS, Ga.--(BUSINESS WIRE)--Guided Therapeutics, Inc. (OTC:QB GTHP), the maker of the LuViva Advanced Cervical Scan, announced today that it had received a payment of $80,000 from distribution partner Hangzhou Dongye Medical Technology Company Ltd (HDMT). The payment is the fourth installment of a $700,000 purchase order the Company received from HDMT last year. The four LuViva devices are expected to…

Business Wire • Jul 22, 2026
Guided Therapeutics Files Premarket Approval Application Clinical Report with FDA

PEACHTREE CORNERS, Ga.--(BUSINESS WIRE)--Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of the LuViva Advanced Cervical Scan, a rapid and painless testing platform for cervical cancer detection based on its patented biophotonic technology, announced today it had filed the results of its multicenter clinical trial with the U.S. Food and Drug Administration (FDA). The study protocol was developed through…

Business Wire • Jun 16, 2026

🧮 Earnings Move Analyzer

Insider Trading

Insider Trading

NameRoleDateTypeSharesPriceFormLink

No Senate trades found for GTHP.

No House trades found for GTHP.

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top